Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $865,000 | $504,000 | +71.63% |
Operating Income | $-148.42M | $-140.59M | -5.57% |
Net Income | $-136M | $-116.59M | -16.64% |
EPS (Basic) | $-1.58 | $-1.43 | -10.49% |
EPS (Diluted) | $-1.58 | $-1.43 | -10.49% |
R&D Expense | $72.48M | $76.17M | -4.84% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.17B | $2.44B | -11.19% |
Current Assets | $1.87B | $2.12B | -11.89% |
Total Liabilities | $336.94M | $355.08M | -5.11% |
Current Liabilities | $119.45M | $118.99M | +0.38% |
Stockholders' Equity | $1.83B | $2.08B | -12.23% |
Cash & Equivalents | $235.18M | $707.43M | -66.76% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-53.95M | $109.75M | -149.15% |
Investing Cash Flow | $-19.75M | $-97.8M | +79.80% |
Financing Cash Flow | $10.59M | $305.93M | -96.54% |
D&A | $4.74M | $4.83M | -2.01% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -17158.8% | -27894.2% | +10735.40% |
Net Margin | -15722.1% | — | — |
ROE | -7.4% | — | — |
ROA | -6.3% | — | — |
Current Ratio | $15.635 | — | — |
Debt to Equity | $0.184 | — | — |
Other companies in Biotechnology